Schizophrenia.com
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics
News
everhopeful
January 31, 2026, 9:23pm
1
1 Like
Related topics
Topic
Replies
Views
Activity
Efficacy and safety of evenamide, a glutamate modulator, added to a second-generation antipsychotic in inadequately/poorly responding patients with chronic schizophrenia:
News
0
54
December 22, 2024
Can anyone explain to me the mechanism of action of evenamide and why it will or won't work?
Medications
13
1156
October 8, 2017
Evenamide boosts symptom improvement in treatment-resistant schizophrenia
News
2
310
October 29, 2023
Newron TRS Study 6 Months’ Results: Evenamide Substantially Improves Patients to an Extent That They No Longer Meet Protocol Entry Criteria
News
11
651
October 12, 2023
Newron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia
News
5
694
June 9, 2022